New 'highly effective' biomarker for lung cancer

5 June 2015

New research has identified a highly effective biomarker in lung cancer, which could help diagnose and improve survival rates for the disease.

It is already known that spotting lung cancer in the first stages significantly improves the chance of survival. Finding biomarkers are key for detecting the disease before any symptoms present themselves.

Published in the journal Oncotarget, a new study has found a protein that circulates and appears to be more accurate at spotting non-small cell lung cancer (NSCLC) than current methods.

These findings, by a team at the Wistar Institute, will need to be confirmed by a larger trial but could lead to a blood test that is easier to use and more accurate in diagnosis. 

Due to the increased accuracy, the test could also be better at distinguishing between benign lung tumours and malignant ones that can grow and spread. 

Dr Qihong Huang, associate professor in the Tumor Microenvironment and Metastasis Program at the Wistar Institute and lead author of the study, said:. "If we can develop a simple blood test that's more accurate than low-dose CT scans, we can detect the cancer earlier with a less expensive, less invasive and more accurate blood test."

Posted by Edward Bartel

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Image Credit: AlexRaths/Thinkstock

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cancer

© Spire Healthcare Group plc (2016)